NDC 80425-0033-03 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0033
- Requested NDC
- 80425-0033-03
- Package NDCs from labels
- 80425-0033-4, 80425-0033-1, 80425-0033-2, 80425-0033-3, 80425-0033-5, 80425-0033-6, 80425-0033-03
- Manufacturer
- Advanced Rx of Tennessee, LLC
- Effective date
- 2026-03-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Advanced Rx of Tennessee, LLC | Advanced Rx of Tennessee, LLC | 2026-03-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0033-1 | Gabapentin | 30 in 1 BOTTLE | CAPSULE | 30 | 12 | |
| 80425-0033-2 | Gabapentin | 60 in 1 BOTTLE | CAPSULE | 60 | 12 | |
| 80425-0033-3 | Gabapentin | 90 in 1 BOTTLE | CAPSULE | 90 | 12 | |
| 80425-0033-4 | Gabapentin | 40 in 1 BOTTLE | CAPSULE | 40 | 12 | |
| 80425-0033-5 | Gabapentin | 120 in 1 BOTTLE | CAPSULE | 120 | 12 | |
| 80425-0033-6 | Gabapentin | 9 in 1 BOTTLE | CAPSULE | 9 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0033 | GABAPENTIN CAPSULE [ADVANCED RX OF TENNESSEE, LLC] | 10 | Current NDC, Legacy NDC, 6 package rows | 20250221_afc83432-8fce-6d2a-e053-2a95a90ae73f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0033-1 | EA - Each | 80425-0033 | 9436a3ad-de85-4153-a6c1-1bc48a0c0ea9 | 1 | 2023-06-06 |
| 80425-0033-2 | EA - Each | 80425-0033 | f1d09a02-72a4-486f-a426-6c8d6d9fd956 | 1 | 2023-06-06 |
| 80425-0033-3 | EA - Each | 80425-0033 | 98f4b8be-49fb-4eaa-b05b-544343fd0e05 | 1 | 2023-06-06 |
| 80425-0033-4 | EA - Each | 80425-0033 | a3084993-3234-4a78-b106-1d887c7721c4 | 1 | 2023-06-06 |
| 80425-0033-5 | EA - Each | 80425-0033 | 869fe2d3-45a1-4521-b1b8-9b0a28976912 | 1 | 2025-03-04 |
| 80425-0033-6 | EA - Each | 80425-0033 | 2cb2f884-e0fb-4a65-b21b-67d983685b75 | 1 | 2026-04-20 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 3dac0d5f-6e65-4c58-9d2a-4f6910b2d4ef | 2026-10-08 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | REMEDYREPACK INC. | 915cee37-536c-4761-bdb9-b96c7ee0f956 | 2026-10-08 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Redpharm Drug | 58474aa7-7c6a-3a94-e063-6394a90a870b | 2026-10-02 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | 57492b91-1fe2-74ab-e063-6394a90a0b9e | 2026-10-02 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 09736975-2493-4dbc-bbe0-cc56a1fec53f | 2026-09-28 | Warnings, Adverse reactions | ANDA090858 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | ScieGen Pharmaceuticals, Inc. | 16542ee6-0e0e-4d3c-8b32-60ff6ef48846 | 2026-09-25 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Asclemed USA, Inc. | 1f1203f4-2184-4e13-e063-6394a90a4330 | 2026-09-23 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | 330ddc5d-c67c-33dc-e054-00144ff88e88 | 2026-09-23 | Warnings, Adverse reactions | ANDA090858 310431 6CW7F3G59X |
| gabapentin | GABAPENTIN | REMEDYREPACK INC. | 49d314cb-90c5-4351-aa42-5838d5f7db28 | 2026-09-23 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 3e633cd0-5ee8-4a05-bcfc-0a80209bf27f | 2026-09-22 | Warnings, Adverse reactions | ANDA090858 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 896c7782-1137-454b-aaa6-28f42c7413ef | 2026-09-21 | Warnings, Adverse reactions | ANDA090858 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Major Pharmaceuticals | 36f74fdf-0dae-47a0-a7ea-e64ac91cd88f | 2026-09-17 | Warnings, Adverse reactions | ANDA090858 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 429a1bb5-babf-4f36-8264-46d71164f1c0 | 2026-09-16 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | REMEDYREPACK INC. | fbeccab7-08aa-4da3-868f-b47a1f3d41ef | 2026-09-14 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 1ec2e07e-5a8e-41e5-9ece-485431c7c4ee | 2026-09-11 | Warnings, Adverse reactions | 6CW7F3G59X |
| gabapentin | GABAPENTIN | REMEDYREPACK INC. | 4a975ebe-ae0a-446a-8a3d-2ca325e28f93 | 2026-09-11 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Advanced Rx of Tennessee, LLC | 5b3ba5e9-6e96-dea6-e063-6394a90aa2bb | 2026-09-11 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Cardinal Health 107, LLC | 934244c6-243d-436e-ad6c-f7bd28e45a86 | 2026-09-11 | Warnings, Adverse reactions | ANDA090858 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Clinical Solutions Wholesale, LLC | b7f9a106-52c6-49e4-acf5-8fb07761ba4f | 2026-09-09 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals,Inc. | d35cd5ac-5ed6-2405-e053-2995a90a6946 | 2026-09-03 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.